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Abstract: The human genome demonstrates variable levels of instability during ontogeny. Achieving the highest rate dur-
ing early prenatal development, it decreases significantly throughout following ontogenetic stages. A failure to decrease or 
a spontaneous increase of genomic instability can promote infertility, pregnancy losses, chromosomal and genomic dis-
eases, cancer, immunodeficiency, or brain diseases depending on developmental stage at which it occurs. Paradoxically, 
late ontogeny is associated with increase of genomic instability that is considered a probable mechanism for human aging. 
The latter is even more appreciable in human diseases associated with pathological or accelerated aging (i.e. Alzheimer’s 
disease and ataxia-telangiectasia). These observations resulted in a hypothesis suggesting that somatic genomic variations 
throughout ontogeny are determinants of cellular vitality in health and disease including intrauterine development, postna-
tal life and aging. The most devastative effect of somatic genome variations is observed when it manifests as chromosome 
instability or aneuploidy, which has been repeatedly noted to produce pathologic conditions and to mediate developmental 
regulatory and aging processes. However, no commonly accepted concepts on the role of chromosome/genome instability 
in determination of human health span and life span are available. Here, a review of these ontogenetic variations is given 
to propose a new “dynamic genome” model for pathological and natural genomic changes throughout life that mimic 
those of phylogenetic diversity. 
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INTRODUCTION 
  Natural variation in the genome at DNA sequence and 
chromosome level is a pervasive feature of eukaryotes un-
derlying phylogenetic diversity of chromosome structure and 
numbers among species during evolution [1, 2]. Similar 
processes seem to occur during ontogeny in the same organ-
ism and commonly manifest as chromosome instability 
(CIN) or aneuploidization [3]. In humans, CIN/aneuploidiza-
tion affects almost all conceptions and achieves the highest 
rate in day 3 or preimplantation embryos or the first trimester 
of prenatal development [4-7]. At the following developmen-
tal stages, the rates seem to decrease significantly either 
through programmed cell death or through spontaneous 
aborting. This leads to at least threefold decrease of instabil-
ity rates after birth [5, 8-10]. However, persisting throughout 
cellular divisions probably due to failed clearance of affected 
cells, such instabilities may give rise to pathological condi-
tions. More precisely, CIN manifesting as somatic ane-
uploidy is associated with abnormal prenatal development, 
chromosomal syndromes, cancer, and brain diseases [8, 9, 
11-18]. Therefore, acquired genomic instability (GIN) initi-
ated by CIN/aneuploidization can be considered as a regula-
tory developmental process and, if failed, a mechanism for 
human prenatal mortality and postnatal morbidity. Addition-
ally, related manifestations of GIN and CIN are consistently  
 
 
*Address correspondence to these authors at the National Research Center 
of Mental Health, Russian Academy of Medical Sciences, Zagorodnoe sh. 2, 
Moscow 119152, Russia; Tel: 7 495 952 89 90; Fax: 7 495 952 89 40;   
E-mails: y_yurov@yahoo.com, ivan_iourov@yahoo.com 
observed to hallmark human aging and are suggested to re-
sult from exhausting of mitotic machinery [19-22]. The lat-
ter, however, remains uncertain, because GIN, CIN and ane-
uploidzation are also observed in aged tissues, which are 
composed of post-mitotic cells (i.e. brain). Recently, a hy-
pothesis has been developed to solve this paradox through 
changing current assessing of time-scale of biological proc-
esses with new twists on GIN/CIN effect on cellular homeo-
stasis [22]. Nonetheless, there are no available and com-
monly accepted concepts on the role of genetic instabilities 
in determination of human health or life span. To fill this 
gap, a review of ontogenetic variation of the human genome 
appears to be required. 
SOMATIC GENOME VARIATIONS (SGV) DURING 
PRENATAL DEVELOPMENT 
  There are numerous evidences for high rates of SGV in 
human embryos. Up to 50% of human conceptions appear to 
be aneupoid, representing, therefore, cases of unstable ge-
nome due to meiotic nondisjunction [3, 8, 9, 23-25]. How-
ever, the overwhelming majority of aneuploid embryos seem 
to be spontaneously aborted at the following developmental 
stages [3, 8, 26]. Nonetheless, studying of preimplantation 
embryos that demonstrates genomic variations at the next 
ontogeny stages depicts occurrence of SGV in almost all 
specimens affecting no less than 20-50% of cells [3, 8, 23, 
24, 27]. The latter is supposed to manifest essentially as ane-
uploidy, but more recent reports have shown other types of 
CIN (structural genomic rearrangements) to be involved, as 
well [7]. Consequently, the instabilities are hypothesized to Ontogenetic Variation of the Human Genome  Current Genomics, 2010, Vol. 11, No. 6    421 
diminish through the prenatal development. Otherwise, a 
pathological condition is likely to occur [3, 8, 22]. Unfortu-
nately, no direct evidences for this are, as yet, available, but 
analysis of spontaneous abortions and brain diseases in chil-
dren supports these assumptions [8, 13, 15, 28, 29]. Another 
feature of CIN during early ontogeny stages is the ability to 
confine to a tissue. The best documented in this context is 
chromosomal mosaicism confined to placenta that is identi-
fied in about 1-2% of all the conceptions by prenatal diagno-
sis [30]. Another documented cause of tissue-specific chro-
mosomal mosaicism is the confinement of aneuploidy to the 
developing human brain [6]. Fetal ovarian tissues seem to 
exhibit increased rates of aneuploidy involving chromosome 
21, as well [25]. Additionally, non-random tissue-specific 
distribution of karyotypically abnormal cells is observed in 
prenatally analyzed cases of supernumerary marker chromo-
somes [31]. Table 1 summarizes available data on develop-
mental CIN in humans. These observations evidence that a 
variety of CIN-associated processes does occur in human 
fetuses and suggest a definitive role of SGV in human prena-
tal development. CIN manifesting as aneuploidy appears to 
be involved in the normal human placentation [32]. As to the 
establishment of the role that developing CIN and ane-
uploidization plays, one can propose to compare CIN rates 
before and after birth. 
SGV DURING POSTNATAL LIFE: LATE ON-
TOGENY AND AGING DISEASES 
  Unfortunately, data on SGV in the early postnatal life of 
unaffected individuals is almost unavailable. Nevertheless, 
controls in studies of brain diseases in childhood exhibit in-
significant rates of mosaic aneuploidy and CIN [13, 18, 33]. 
A comparison of sporadic aneuploidy rates in the developing 
and adult human brain shows an exact threefold decrease [5, 
6, 8, 10, 16, 18, 33]. Otherwise, related studies were per-
formed for the clinical population only [3, 8, 9, 15, 34, 35]. 
Human aging tissues appear to be more thoroughly studied 
in this context. Therefore, there is a gap in our knowledge 
about ontogenetic variations of the human genome in child-
hood and early adulthood. However, to define whether GIN 
or CIN increases during human life, control population, that 
is usually individuals of adult or middle age, has been ana-
lyzed [20, 22, 36-39]. Another possibility to prove the exis-
tence and effects of age-related SGV is referred to studying 
diseases associated with accelerated or pathological aging 
[22]. Currently, there are more than 30 diseases that are as-
sociated with GIN, CIN and aging. However, only few of 
them were evaluated in the light of genome variations mani-
festing as GIN or CIN. Among these are some monogenic 
CIN syndromes, Alzheimer’s disease (AD) and Down syn-
drome (trisomy of chromosome 21) [18, 22, 33, 40, 41]. Ad-
ditionally, aneuploidy, as a whole, is likely to cause acceler-
ated senescent phenotypes either at cellular or at organismal 
level [17, 22, 42-45]. The latter is also observed in cancer-
predisposing diseases (i.e. ataxia-telangiectasia or AT) and in 
malignant tissues [18, 21, 33, 40, 41]. Table 2 summarizes 
natural genome variations through human aging and 
GIN/CIN in aneuploidy-associated and aging diseases. 
  As one can see (Table 2), regardless of the stage of on-
togeny, an increase of GIN and CIN causes aging pheno-
types. However, normal ontogenetic variations of the human 
genome are more apparent when aging tissues are studied [5, 
10, 16, 18, 20, 22, 36-39]. This raises an important question 
about their origins. Firstly, GIN and CIN (aneuploidization) 
cause a wide spectrum of diseases both in childhood and in 
adulthood [8, 9, 11-18, 26, 29, 33-35]. Additionally, some 
GIN/CIN signatures such as uniparental disomy due to in-
trauterine trisomy rescue via confined placental mosaicism 
[46] and low-level chromosomal mosaicism in child and 
adult individuals [3, 8, 9, 34] have been reported. Taken to-
gether, it suggests previous (GIN’n’CIN) hypothesis applied 
Table 1.  CIN in Human Conceptions During the Prenatal Development 




NA  Aneuploidy  +  +  [21, 24, 27] 
Preimplantation embryos 
NA Aneuploidy/structural  abnormalities  +  ?  [7] 
Chorionic villi  Aneuploidy  +  -  [6] 
Brain   Aneuploidy  +  ?  [5, 6] 
Skin   Aneuploidy  +  -  [6] 
Fetuses at 7-12 weeks 
gestation 
Ovarian tissue  Aneuploidy  +  -  [25] 
Spontaneous abortions (7-
15 weeks gestation) 
Chorionic villi   Chromosomal mosaicism (aneuploidy)  - +  [28] 





Chromosomal mosaicism (aneuploidy)  +  -  [30] 





Derivative chromosomes (marker chro-
mosomes) 
- +  [31] 
NA — not applicable. 422    Current Genomics, 2010, Vol. 11, No. 6  Yurov et al. 
Table 2.  GIN and CIN (SGV) Associated with Normal Human Aging and Aging Diseases 
Condition  Tissue/Cell Types  Overview of Instability  Key Refs 
Natural genomic variations during normal aging 
Blood lymphocytes 
Chromosome X: 1.5%-2.5% and 4.5%-7.3%*; Chromosome Y loss: 
0.17%; 
Autosomes: 1.2% and 1-2%* 
[20, 36, 37, 
39] 
Skin fibroblasts  2,2% and 4,4%*  [38]  Normal aging 
Brain 
0.3-0.9% and 1.4-3%* 
(no targeted studies of the  
aging brain are, as yet, available) 
[5, 10, 16,  
18, 22, 33] 
Aneuploidy and aneuploidy-associated/aging diseases 




Blood lymphocytes (other tissues are 
rarely analyzed) 
100% (?) of cells with additional chromosome 21 cause accelerated 
aging phenotype 
[17, 25, 43] 
AT Brain 
Aneuploidy and chromosome breakage producing additional rearranged 
chromosomes (partial aneuploidy) confine to the degenerated cerebel-
lum and affect up to 40% of cells 
[18, 33] 
Brain  Chromosome 21 aneuploidy affecting 6-15% of brain cells  [18] 
Transfected human presenelin1-mutated 
cells  
Acquired chromosome missegregation causing aneuploidy associated 
with abnormal presenelin 1 functioning 
[44] 
AD 
Transgenic mice and 
transfected human cells 
Amyloid precursor protein 
gene (APP) induce chromosome missegregation and aneuploidy 
[45] 
Cancers  Almost all types of malignant tissues/cells 
Aneuploidy hallmarks almost all cancers; aneuploid cells exhibit senes-
cent phenotype 
[14, 21, 40, 
41] 
* — middle age and aged individuals, respectively. 
to the human brain [22] to be also true for all the human tis-
sues. Thus, the timeline of ontogenetic genomic variations 
mediated by GIN, CIN or aneuploidization is as follows: 
CIN achieves the highest rate during early perinatal devel-
opment, then GIN/CIN signatures are only observed (apart 
from pathologic conditions) and, finally, it begins to increase 
in late ontogeny. This appears to fit well data on SGV in 
different human tissues and implicates mitotic machinery 
exhausting as the main cause of aging-associated GIN/CIN 
progression [19, 22]. However, post-mitotic cells are un-
likely to become aneuploid via these mechanisms [22]. Nev-
ertheless, molecular cytogenetic replication analyses that 
depict mitotically non-arrested cells [47-49], yielded positive 
results in the diseased brain [50]. Further studies have dem-
onstrated gene mutations associated with early-onset AD to 
be involved in mitotic chromosomal missegregation leading 
to CIN [44, 45]. Despite of chromosome 21-aneuploidization 
of the AD brain [18], this hypothesis can still be challenged, 
because of highly specific CIN manifestation and technical 
limitations of single-cell molecular cytogenetic replication 
analyses. To solve this paradox, positive data from all the 
molecular cytogenetic studies of the AD brain and AD mod-
els have been gathered [51]. This resulted in a model propos-
ing that accumulation of GIN and CIN due to abnormal mi-
totic behavior of brain cells during prenatal development and 
early childhood followed by natural selection leads to persis-
tence of chromosome 21-aneuploid cells, which produce 
recognizable disease phenotype in the late ontogeny [22, 51]. 
This accords well with observations of monogenic AD mod-
els [44, 45]. Similar processes seem to underlie AT patho-
genesis with the sole exception that GIN/CIN manifests in 
the early childhood, probably due to specifity of genome 
maintaining protein behavior encoded by the AT-causing 
gene (ATM) as well as more pathogenic value of CIN [18, 
33]. However, one has to keep in mind that GIN and CIN in 
aging diseases are evaluated after manifestation. Therefore, 
no data is available on previous ontogenetic periods. Still, to 
get an integrated view of somatic genome changes through-
out ontogeny, data on origins of genomic variations (so-
matic, germline or syntenic), their associations with aging 
phenotypes and parental development can be used. 
ONTOGENETIC VARIATIONS OF THE GENOME: 
PHYLOGENY-ONTOGENY PARALLELS AND UP-
DATED “GIN’N’CIN” HYPOTHESIS 
  Summarizing the data described above, we have pro-
posed a schematic graph showing the trend of genome varia-
tion throughout ontogeny due to natural intercellular genome Ontogenetic Variation of the Human Genome  Current Genomics, 2010, Vol. 11, No. 6    423 
variations and in aging diseases associated with GIN and 
CIN (Fig. 1). The graph also indicates ontogenetic stages 
that need to be analyzed for definition of mechanisms by 
which SGV are formed and maintained throughout develop-
ment to produce the aging phenotype (at least in AT and 
AD). As to natural ontogenetic genome variations, the dy-
namics appear to be better understood [3, 8]. However, this 
has to be thoroughly re-evaluated and the data on benign 
SGV have to be provided.  
  Since the evaluation of SGV evidences that the human 
genome is subjected to dynamic changes during ontogeny, it 
appears appropriate to refer to “dynamic genome”, a term 
introduced to define the process of transposition of mobile 
genetic elements changing the amount of DNA in the ge-
nome. Discovered more than 50 years ago by Barbara 
McClintock, it was used to explain numerous genetic proc-
esses including genome changes during phylogeny [52]. Cur-
rent concepts in genome research allow to extrapolate prin-
ciples of phylogenomics to SGV [3, 53]. This is, in parts, 
inspired by the observations of parallels between chromo-
some number/structure or DNA sequence variations along 
branches of the phylogeny and somatic mutations manifest-
ing as GIN or CIN along ontogeny [3, 22, 53-56]. If phylo-
genomic principles are applied to cellular genomes, Darwin-
ian or natural selection appears to play a role not only in evo-
lution, but also in brain diseases and cancer [3, 53, 54, 56]. 
As one can see, it can be also successfully applied to the 
normal human development and aging (ontogeny), as well 
[3, 6, 9, 22, 53, 54]. Therefore, during prenatal development, 
aneuploidization or CIN/GIN serves as a mechanism for 
regulation of cell population size through the clearance of 
abnormal cells or growth arrest [6, 8, 22, 32, 51, 57]. The 
lack of clearance or increase of cell viability due to genomic 
variations (as in malignant cells) would lead to pathological 
conditions such as aneuploidy-associated diseases or can-
cers. In the late ontogeny, increase of CIN/GIN would lead 
to aging phenotype due to either a failure of abnormal cell 
clearance or aging-related alterations to mitotic machinery. 
The aging tissues composed of post-mitotic cells seem to 
become senescent by a different mechanism that is probably 
related to changes of genome expression in cells with ab-
normal chromosome complement accumulated at earlier on-
togenetic stages. To this end, “dynamic genome” model in 
the ontogenetic sense can be postulated as follows: SGV in 
early prenatal development reach its highest rate in order to 
highlight cells for cell clearance machinery (this makes a 
decrease of abnormal cell content); at the following ontoge-
netic stages, the amount of cells with altered genome exhib-
its less significant variation, which is undetectable by avail-
able techniques; in the latest ontogenetic stages, a re-increase 
of SGV rates is observed and is associated with aging; fi-
nally, the rates of ontogenetic genome variations are proba-
bly specific for each tissue. 
CONCLUDING REMARKS 
  Currently, almost all the studies in the fields of human 
genetics and genomics operate with “an average cell ge-
nome”. The approach allows the determination of genomic 
variations between individuals. Although it is unavoidable to 
apply such technologies for genomic studies, SGV cannot be 
adequately described by techniques analyzing DNA isolated 
from a large pool of cells. As a result, much less attention is 
paid to such phenomena as ontogenetic variations of the hu-
man genome, which are impossible to evaluate by studying 
“average cell genome”. Single-cell genomic as well as single 















Fig. (1). Schematic representation of SGV manifested as GIN/CIN changing during ontogeny due to natural variations of the genome and in 
aging diseases: AT (CIN syndrome) and AD. Being increased in the early prenatal development, GIN/CIN decreases throughout following 
ontogeny stages, showing, however, a slight increase in the late ontogeny. In cases of CIN syndromes, GIN/CIN probably decreases insig-
nificantly and demonstrates high rates after birth as exemplified by studying the AT brain [17, 32]. AD is suggested to be associated with 
failed clearance of cells affected by GIN/CIN exhibiting high rates of the chromosome 21 aneuploidy in diseased brain analyzed after the 
manifestation (late ontogeny) [7, 17, 21]. Intervals marked by question symbol show ontogenetic periods that have not been studied in con-
text of SGV. 424    Current Genomics, 2010, Vol. 11, No. 6  Yurov et al. 
58] and their results are much more difficult to interpret. 
Nevertheless, several molecular cytogenetic studies demon-
strated the existence of SGV and their role in normal human 
development, disease and aging. Regardless of available 
data, which allows to propose hypotheses and models de-
scribing genome variations over the human lifespan, ontoge-
netic genome research requires additional studies. Taking 
into account that genome variations are likely to be specific 
for each ontogenetic stage and each tissue, one can imagine a 
large amount of work still to be performed. The present 
model and an update of GIN’n’CIN hypothesis intend to 
shed light on the genome behavior during ontogeny in health 
and disease. The future of genomic research appears to be 
linked with single-cell biology that refutes the “average cell 
concept” and postulates a continuous (structural and func-
tional) variation of cellular genome. Therefore, further stud-
ies of the human genome would be incomplete without ad-
dressing its ability to dynamically change along ontogeny. 
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